PT - JOURNAL ARTICLE AU - Suetani, Shuichi AU - Baker, Andrea AU - Garner, Kelly AU - Cosgrove, Peter AU - Mackay-Sim, Matilda AU - Siskind, Dan AU - Murray, Graham K AU - Scott, James G AU - Kesby, James P TI - Impairments in goal-directed action and reversal learning in a proportion of individuals with psychosis: evidence for differential phenotypes in early and persistent psychosis AID - 10.1101/2021.08.31.21262937 DP - 2021 Jan 01 TA - medRxiv PG - 2021.08.31.21262937 4099 - http://medrxiv.org/content/early/2021/09/02/2021.08.31.21262937.short 4100 - http://medrxiv.org/content/early/2021/09/02/2021.08.31.21262937.full AB - Cognitive impairments in psychosis are one of the strongest predictors of functional decline. Cortico-striatal dysfunction may contribute to both psychosis and cognitive impairment in psychotic illnesses. The decision-making processes underlying goal-directed action and serial reversal learning can be measured and are sensitive to changes reflecting cortico-striatal dysfunction. As such, changes in decision-making performance may assist with predicting functional decline in people with psychosis. We assessed decision-making processes in healthy controls (N=34), and those with early psychosis (N=15) and persistent psychosis (N=45). We subclassified subjects based on intact/impaired goal-directed action. Compared with healthy controls (<20%), a large proportion (58%) of those with persistent psychosis displayed impaired goal-directed action, predicting poor serial reversal learning performance. Computational approaches indicated that those with persistent psychosis were less deterministic in their decision-making. Those with impaired goal-directed action had a decreased capacity to rapidly update their prior beliefs in the face of changing contingencies. In contrast, the early psychosis group included a lower proportion of individuals with impaired goal-directed action (20%) and displayed a different cognitive phenotype from those with persistent psychosis. These findings suggest prominent decision-making deficits, indicative of cortico-striatal dysfunction, are present in a large proportion of people with persistent psychosis while those with early psychosis have relatively intact decision-making processes compared to healthy controls. It is unclear if there is a progressive decline in decision-making processes in some individuals with psychosis or if the presence of decision-making processes in early psychosis is predictive of a persistent trajectory of illness.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by an Advance Queensland Research Fellowship (AQRF04115-16RD1 to JPK), a University of Queensland Early Career Researcher Grant (JPK), a Brisbane Diamantina Health Partners Grant (JPK and SS) and a Brain & Behavior Research Foundation Maltz Prize (JPK). AB and PC employed by, and SS and JGS are affiliated with, the Queensland Centre for Mental Health Research which receives core funding from Queensland Health. JGS is supported by a National Health and Medical Research Council Practitioner Fellowship Grant (APP1105807).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All procedures were approved by the Royal Brisbane and Women's Hospital, and University of Queensland Human Research Ethics Committees (HREC/17/QRBW/168).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data are available upon request.